Bone morphogenetic protein-2 activity is regulated by secreted phosphoprotein-24 kd, an extracellular pseudoreceptor, the gene for which maps to a region of the human genome important for bone quality

Metabolism: Clinical and Experimental

Volumn 58, Issue 5, 2009, Pages 644-650

  Brochmann, Elsa J ^a,b   Behnam, Keyvan ^c   Murray, Samuel S ^a,b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Lanx Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CCAAT ENHANCER BINDING PROTEIN; CYSTEINE; FETUIN; GROWTH HORMONE; SCLEROPROTEIN; SECRETED PHOSPHOPROTEIN 18.5; SECRETED PHOSPHOPROTEIN 24; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG;

ARTICLE; BONE DENSITY; BONE MASS; BONE METABOLISM; CALCANEUS; CELL DIFFERENTIATION; CELL PROLIFERATION; DISULFIDE BOND; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENE MAPPING; GENE OVEREXPRESSION; HUMAN; HUMAN GENOME; OSSIFICATION; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; QUANTITATIVE TRAIT LOCUS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ULTRASOUND;

AMINO ACID SEQUENCE; ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEIN 2; CATTLE; CHROMOSOME MAPPING; GENOME, HUMAN; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; OSTEOPOROSIS; PHOSPHORIC MONOESTER HYDROLASES; QUANTITATIVE TRAIT LOCI;

EID: 64349109481     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.01.001     Document Type: Article

References (60)

1. Huang W.Y., and Kung A.W.C. Genetics of osteoporosis. Mol Genet Metab 88 (2006) 295-306
2. Peacock M., Turner C.H., Econs M.J., and Foroud T. Genetics of osteoporosis. Endocr Rev 23 (2002) 303-326
3. Thijssen J.H.H. Gene polymorphisms involved in the regulation of bone quality. Gynecol Endocrinol 22 (2005) 131-139
4. Nguyen T.V., Blangero J., and Eisman J.A. Genetic epidemiological approaches to the search for osteoporosis genes. J Bone Miner Res 15 (2000) 392-401
5. Eisman J.A. Genetics of osteoporosis. Endocr Rev 20 (1999) 788-804
6. Stewart A., and Reid D.M. Quantitative ultrasound or clinical risk factors-which best identifies women at risk of osteoporosis?. Br J Radiol 73 (2000) 165-171.7
7. Genant H.K., Lang T.F., Engelke K., Fuerst T., Gluer C., Majumdar S., et al. Advances in the noninvasive assessment of bone density, quality, and structure. Calcif Tissue Int 59 (1996) S10-S15
8. Strelitzki R., Evans J.A., and Clarke A.J. The influence of porosity and pore size on the ultrasonic properties of bone investigated using a phantom material. Osteoporos Int 7 (1997) 370-375
9. Cortet B., Boutry N., Dubois P., Legroux-Gerot I., Cotton A., and Marchandise X. Does quantitative ultrasound of bone reflect more bone mineral density than bone microarchitecture?. Calcif Tissue Int 74 (2004) 60-67
10. Duquette J., Honeyman T., Hoffman A., Ahmadi S., and Baran D. Effect of bovine bone constituents on BUA measurements. Bone 21 (1997) 289-294
11. Han S., Medige J., Faran K., Feng Z., and Ziv I. The ability of QUS to predict the mechanical properties of trabecular bone under different strain rates. Med Eng Phys 19 (1997) 742-747
12. Cunningham J.L., Fordham J.N., Hewitt T.A., and Speed C.A. Ultrasound velocity and attenuation at different skeletal sites compared with bone mineral density measured using dual energy X-ray absorptiometry. Br J Radiol 69 (1996) 25-32
13. Porter R.W., Miller C.G., Grainger D., and Palmer S.B. Prediction of hip fracture in elderly women: a prospective study. BMJ 301 (1990) 638-641
14. Krieg M.A., Cornuz J., Ruffieux C., Sandini L., Buche D., Dambacher M.A., et al. Comparison of three bone ultrasounds for the discrimination of subjects with and without osteoporotic fractures among 7562 elderly women. J Bone Miner Res 18 (2003) 1261-1266
15. Frost M.L., Blake G.M., and Fogelman I. A comparison of fracture discrimination using calcaneal quantitative ultrasound and DEXA in women with a history of fracture at sites other than the spine and hip. Calcif Tissue Int 71 (2002) 207-211
16. Knapp K.M., Andrew T., MacGregor A.J., Blake G.M., Fogelman I., and Spector T.D. An investigation of unique and shared gene effects on speed of sound and bone density using axial transmission quantitative ultrasound and DXA in twins. J Bone Miner Res 18 (2003) 1525-1530
17. Zajickova K., Zofkova I., and Hill M. Vitamin D receptor polymorphisms, bone ultrasound, and mineral density in post-menopausal women. Aging Clin Exp Res 17 (2005) 121-124
18. Tsuritani I., Brooke-Wavell K.S., Mastana S.S., Jones P.R., Hardman A.E., and Yamada Y. Does vitamin D receptor polymorphism influence the response of bone to brisk walking in postmenopausal women?. Hormone Res 50 (1998) 315-319
19. Andrew T., Mak Y.T., Reed P., MacGregor A.J., and Spector T.D. Linkage and association for bone mineral density and heel ultrasound measurements with a simple tandem repeat polymorphism near the osteocalcin gene in female dizygotic twins. Osteoporosis Int 13 (2002) 745-754
20. 2-HS-glycoprotein is related to calcaneal broadband ultrasound attenuation in older women. Calcif Tissue Int 63 (1998) 5-8
21. Albagha O.M., Pettersson U., Stewart A., McGuigan F.E., MacDonald H.M., Reid D.M., et al. Association of oestrogen receptor alpha gene polymorphisms with postmenopausal bone loss, bone mass, and quantitative ultrasound properties of bone. J Med Genet 42 (2005) 240-246
22. Nordstrom A., Gerdhem P., Brandstrom H., Stiger F., Lerner U.H., Lorentzon M., et al. IL-6 promoter polymorphism is associated with bone quality assessed by calcaneous ultrasound and previous fractures in a cohort of 75-year-old women. Osteoporosis Int 15 (2004) 820-826
23. Koh J.M., Nam-Goong I.S., Hong J.S., Kim H.K., Kim J.S., Kim S.Y., et al. Oestrogen receptor alpha genotype and interactions between vitamin D receptor and TGF-β1 genotypes are associated with quantitative calcaneal ultrasound in postmenopausal women. Clin Endocrinol 60 (2004) 232-240
24. Jorgensen H.L., Madsen J.S., Madsen B., Saleh M.M., Abrahamsen B., Fenger M., et al. Association of a common allelic polymorphism (C677T) in the methylene tetrahydrofolate reductase gene with a reduced risk of osteoporotic fractures. A case control study in Danish postmenopausal women. Calcif Tissue Int 71 (2002) 386-392
25. McLean R.R., Karasik D., Selhub J., Tucker K.L., Ordovas J.M., Russo G.T., et al. Association of a common polymorphism in the MTHRF gene with bone phenotypes depends on plasma folate status. J Bone Miner Res 19 (2004) 410-418
26. Jorgensen H.L., Kusk P., Madsen B., Fenger M., and Lauritzen J.B. Serum osteoprotegerin (OPG) and the A163G polymorphism in the OPG promoter region are related to peripheral measures of bone mass and fracture odds ratios. J Bone Miner Res 22 (2004) 132-138
27. Weichetova M., Stepan J.J., Haas T., and Michalska D. The risk of Colles' fracture is associated with the collagen I alpha1 Sp1 polymorphism and ultrasound transmission velocity in the calcaneus only in heavier postmenopausal women. Calcif Tissue Int 76 (2005) 98-106
28. Wilson S.G., Reed P.W., Andrew T., Barber M.J., Lindersson M., Langdown M., et al. A genome-screen of a large twin cohort reveals linkage for quantitative ultrasound of the calcaneus to 2q33-37 and 4q12-21. J Bone Miner Res 19 (2004) 270-277
29. Swallow J.E., Merrison W.K., Gill P.K., Harris S., and Dalgleish R. Assignment of secreted phosphoprotein 24 (SPP2) to human chromosome band 2q37->qter by in situ hybridization. Cytogenet Cell Genet 79 (1997) 142
30. Bennett C.S., Khorshid H.R.K., Kitchen J.A., Arteta D., and Dalgleish R. Characterization of the human secreted phosphoprotein 24 gene (SPP24) and comparison of the protein sequence in nine species. Matrix Biol 22 (2004) 641-651
31. Agarwal S.K., Cogburn L.A., and Burnside J. Comparison of gene expression in normal and growth hormone receptor-deficient dwarf chickens reveals a novel growth hormone regulated gene. Biochem Biophys Res Commun 206 (1995) 153-160
32. Hu B., Coulson L., Moyer B., and Price P. Isolation and cloning of a novel bone phosphoprotein related in sequence to the cystatin family of thiol protease inhibitors. J Biol Chem 270 (1995) 431-436
33. Okazaki Y., Furuno M., Kasukawa T., Adachi J., Bono H., Kondo S., et al. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature 420 (2002) 563-573
34. Strausberg R.L., Feingold E., Grouse L.H., Derge J.G., Klausner R., Collins F.S., et al. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. PNAS 99 (2002) 16899-16903
35. Behnam K., Phillips M.L., Silva J.D.P., Brochmann E.J., Duarte M.E.L., and Murray S.S. BMP binding peptide: a BMP-2 enhancing factor deduced from the sequence of native bovine bone morphogenetic protein/non-collagenous protein. J Orthop Res 23 (2005) 175-180
36. 2-HS glycoprotein is a TGF-β type II receptor mimic and cytokine antagonist. J Biol Chem 271 (1996) 12755-12761
37. Price P., and Williamson M. Primary structure of bovine matrix Gla protein, a new vitamin K-dependent bone protein. J Biol Chem 260 (1985) 14971-14975
38. Urist M.R., Huo Y.K., Chang J.J., Hudak R.T., Rasmussen J.K., Hirota W., et al. Hydroxyapatite affinity, electroelution, and RIA for identification of human and bovine bone BMPs and polypeptides. In: Sen A., and Thornhill T. (Eds). Development and diseases of cartilage and bone matrix (1987), Liss, New York (NY) 149-176
39. Zhou H.Y. Proteomic analysis of hydroxyapatite interaction proteins in bone. Ann N Y Acad Sci 1116 (2007) 323-326
40. Brochmann Murray E., Murray S., Simon R., and Behnam K. Recombinant expression, isolation, and proteolysis of extracellular matrix secreted phosphoprotein-24 kDa. Connect Tissue Res 48 (2007) 292-299
41. van den Bos T., Speijer D., Bank R.A., Bromme D., and Everts V. Differences in matrix composition between calvaria and long bone in mice suggest differences in biomechanical properties and resorption. Special emphasis on collagen. Bone 43 (2008) 459-468
42. 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem 278 (2003) 13333-13341
43. Sintuu C., Murray S., Behnam K., Simon R., Jawien J., Silva J., et al. Full-length bovine SPP24 and secretory spp24 [spp24 (residues 24-203)] inhibit BMP-2-induced bone formation. J Orthop Res 26 (2008) 753-758
44. Zanetti M., Gennaro R., and Romeo D. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 374 (1995) 1-5
45. Tack B.F., Sawai M.V., Kearney W.R., Robertson A.D., Sherman M.A., et al. SMAP-29 has two LPS-binding sites and a central hinge. Eur J Biochem 269 (2002) 1181-1189
46. Rozek A., Powers J.P., Friedrich C.L., and Hancock R.E. Structure-based design of an indolicidin peptide analogue with increased protease stability. Biochemistry 42 (2003) 14130-14138
47. Yang Y., Sanchez J.F., Strub M.P., Brutscher B., and Aumelas A. NMR structure of the cathelin-like domain of the protegrin-3 precursor. Biochemistry 42 (2003) 4669-4680
48. Urist M.R., Chang J.J., Lietze A., Huo Y.K., Brownell A.G., and DeLange R.J. Methods of preparation and bioassay of bone morphogenetic protein and polypeptide fragments. Method Enzymol 146 (1987) 294-312
49. Sen A., Walker M., and Einarson B. Purification and partial characterization of a novel osteogenic protein. In: Sen A., and Thornhill T. (Eds). Development and diseases of cartilage and bone matrix (1987), Liss, New York (NY) 201-220
50. Huber W., and Mueller F. Biomolecular interaction analysis in drug discovery using surface plasmon resonance technology. Current Pharm Des 12 (2006) 3999-4021
51. Mace P., Cutfield J., and Cutfield S. High resolution structures of the BMP type II receptor in two crystal forms: implications for ligand binding. Biochem Biophys Res Commun 351 (2006) 831-838
52. Alanay A., Chen C., Lee S., Murray S., Brochmann E., Miyazaki M., et al. The adjunctive effect of a binding peptide on BMP enhanced bone healing in a rodent model of spinal fusion. Spine 33 (2008) 1709-1713
53. Zhou S., Glowacki J., and Yates K.E. Comparison of TGF-beta/BMP pathways signaled by demineralized bone powder and BMP-2 in human dermal fibroblasts. J Bone Miner Res 19 (2004) 1732-1741
54. Stern P. The calcineurin-NFAT pathway and bone: intriguing new findings. Molec Intervent 6 (2006) 193-196
55. Zayzafoon M. Calcium/calmodulin signaling controls osteoblast growth and differentiation. J Cell Biochem 97 (2006) 56-70
56. Koga T., Matsui Y., Asagiri M., Kodama T., de Crombrugghe B., Nakashima K., et al. NFAT and osterix cooperatively regulate bone formation. Nat Med 11 (2005) 880-885
57. McCarthy T.L., Ji C., and Centrella M. Links among growth factors, hormones, and nuclear factors with essential roles in bone formation. Crit Rev Oral Biol Med 11 (2000) 409-422
58. Ogasawara A., Arakawa T., Kaneda T., Takuma T., Sato T., Kaneki H., et al. Fluid shear stress-induced COX-2 expression is mediated by C/EBP, cAMP-response element-binding protein, and AP-1 in osteoblastic MC3T3-E1 cells. J Biol Chem 276 (2001) 7048-7054
59. Tavares A.T., Tsukui T., and Izpisua Belmonte J.C. Evidence that members of the Cut/Cux/CDP family may be involved in AER positioning and polarizing activity during chick limb development. Development 127 (2000) 5133-5144
60. Sharma M., Brantley J.G., Alcalay N.I., Zhou J., Heystek E., Maser R.L., et al. Differential expression of Cux-1 and p21 in polycystic kidneys from Pkd1 null and cpk mice. Kidney Int 67 (2005) 432-442